Learn about USP's involvement in the APEC Life Sciences Innovation Forum and how this group is improving access to quality medical products by helping Asian-Pacific economies prevent, detect and respond to spurious, substandard, falsified, falsely-labelled and counterfeit products in their supply chains.
In the U.S. and around the world, quality standards developed by the U.S. Pharmacopeia (USP) support the availability of safe, quality medicines, regulatory efficiencies, and a strong global medicine supply chain.
In LMICs, the availability of medicines manufactured locally that do not meet quality standards is a leading cause of treatment failure and adverse events in patients and is undermining public health interventions. But where do things go wrong during pharmaceutical manufacturing in LMICs that give rise to this problem? Learn more.
Patrick Lukulay, USP’s VP of GHIP–Africa, discusses plans to leverage his new post in Accra, Ghana to advance pharmaceutical quality in Africa. Countering fallacies in drug quality through advocacy and working to help build an enabling environment that can sustain systems for effective regulation of medical products, he says, are needed for this to happen.
Almost half of the world’s population is at risk of malaria. Malaria Day in the Americas celebrates progress made to prevent, detect, treat and defeat malaria in this region. Learn how Promoting the Quality of Medicines (PQM) is helping by increasing the availability of quality-assured antimalarials.
Access to quality care and medicines is an integral part of public health. For USP, an organization that creates and promotes public standards for medicines and foods, quality and access are two sides of the same coin and in fact the absence of either one actually threatens effectiveness of medical care around the world.
In Liberia, sellers of poor-quality medicines are capitalizing on public fears about Ebola. Learn what the Liberia Medicines and Health Products Regulatory Authority is doing about it and how the Promoting the Quality of Medicines Program--a collaborative effort between USAID and USP--is playing a role.
Consumers often purchase over the counter medicines and dietary supplements without consulting a health care professional. A pharmacist can offer important advice and counsel when choosing these products. Dr. Nandakumara Sarma, Director of USP's Dietary Supplement program and an experienced pharmacist explains why in the final part of our series celebrating American Pharmacists Month.
Mandela Washington Fellow, Dr. Ashiru Abubakar, talks with USP about the drug supply chain, the intersection of public health and political will, and the hope for a future free of counterfeit medicines in his native Nigeria.